Doxorubicin

• Category :

  Intermediates/Pharmaceutical intermediates

• Synonyms :

  10-((3-Amino-2,3,6-trideoxy-alpha-L-lyso-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione;14-Hydroxydaunomycin;(8S-cis)-10-(3-Amino-2,3,6-Trideoxy-alpha-L-Lyxo-Hexopyranosyl)Oxy-7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-5,12-Naphthacenedione;adiblastine (hydrochloride salt);adriablastine (hydrochloride salt);adriablatina (hydrochloride salt);Adriacin;Adriacin (hydrochloride salt);Adriamycin PFS;Adriamycin PFS (hydrochloride salt);Adriamycin RDF;Adriamycin RDF (hydrochloride salt);Adriblastin;Adriblastina;Adriblastina (hydrochloride salt);adriblatina (hydrochloride salt);Doxorubicin;Doxorubicin hydrochloride (hydrochloride salt);Farmablastina (hydrochloride salt);Hydroxydaunomycin hydrochloride (hydrochloride salt);Hydroxydaunorubicin hydrochloride (hydrochloride salt);Rubex;Rubex (hydrochloride salt);(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;

• CAS NO :

  23214-92-8

• EC NO :

  245-495-6

• Molecular Formula :

  C₂₇H₂₉NO₁₁

• Molecular Weight :

  543.5193

• Main Specifications :

• InChI :

  InChI=1/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1

• Molecular Structure :